In the case of the GSTT1 and GSTP1 polymorphisms, there were no statistically significant relationships with the disease (Mo et al. 2009); it was established that the polymorphisms are not related to the risk of prostate cancer. The gene discussed is GSTP1; the disease is prostate carcinoma.